Professor Tim Illidge
At the University of Manchester, Professor Tim Illidge is looking at whether combining different types of treatments is better for treating cancer. Radiotherapy is a cornerstone treatment for cancer, with many cancer patients receiving radiotherapy as part of their treatment. Immunotherapy is a newer treatment, and several immunotherapy drugs are now used to help the body’s immune system to fight cancer.
Professor Illidge is trying to establish the best combination of radiotherapy and immunotherapy for cancer patients. To do this, he is looking at how radiotherapy affects the immune response, how radiotherapy affects the environment within and around the tumours, and how combining radiotherapy with drugs that kick-start the immune system might enhance current treatments.